Bandingkan Harga & Kinerja Malacca Trust Wuwungan Insurance Tbk. (MTWI) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Malacca Trust Wuwungan Insurance Tbk. dan Organon Pharma Indonesia Tbk.: Malacca Trust Wuwungan Insurance Tbk. diperdagangkan di Rp274 (kapitalisasi pasar 795,46 M, volume 24 jam 63,5 rb), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Malacca Trust Wuwungan Insurance Tbk. jauh lebih besar — sekitar 7,6× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| MTWI | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 795,46 M | 104,4 M |
Volume | 63,5 rb | — |
Lot | 635 | — |
Perputaran | 17,37 jt | — |
Harga Rata-rata | 273,54 | — |
Nilai Transaksi | 17,37 jt | — |
Harga Ekuilibrium Indikatif | 274 | — |
Volume Ekuilibrium Indikatif | 39 | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Malacca Trust Wuwungan Insurance Tbk.
PT Malacca Trust Wuwungan Insurance (the Company) formerly known as PT Asuransi wuwungan, was established based on Notarial Deed No. 76 dated December 15, 1952, which was amended based on Deed No. 133 dated January 21, 1953 of Raden Mas Soerojo, S.H., Notary in Jakarta.Since 2011, Malacca Trust Limited, a Singapore-based holding company, through its subsidiaries Batavia Prosperindo International and Batavia Prosperindo Finance, has successfully become a majority shareholder of PT Malacca Trust Wuwungan Insurance. This completes the entire Malacca Trust Limited business in the financial industry where previously it has owned asset management, securities & multi finance company based in Indonesia.
Selengkapnya di halaman MTWI →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
